Structure-based Discovery of Conformationally Selective Inhibitors of the Serotonin Transporter
Preprint
Abstract
SUMMARY: The serotonin transporter (SERT) removes synaptic serotonin and is the target of anti-depressant drugs. SERT adopts three conformations: outward-open, occluded, and inward-open. All known inhibitors target the outward-open state except ibogaine, which has an unusual anti-depressant profile and stabilizes the inward-open conformation. Unfortunately, ibogaine is promiscuous and cardiotoxic, limiting understanding of inward-open state ligands. We computationally docked over 200 million small molecules against the ibogaine stabilized inward-open state of SERT. Thirty-six top-ranking compounds were synthesized and thirteen inhibited with potencies ranging from 29 to 5000 nM. Structure-based optimization led to two novel inhibitors with Ki values down to 3 nM. The new molecules stabilized an outward-closed state of the transporter and had little activity against off-targets. A cryo-EM structure of one of these bound to SERT confirmed the predicted geometry. In mouse behavioral assays, both had anxiolytic and anti-depressant activity, with potencies up to 200 better than fluoxetine.Keywords
All Related Versions
- Published version: Cell, 186 (10), 2160.
This publication has 118 references indexed in Scilit:
- Conformation Guides Molecular Efficacy in Docking Screens of Activated β-2 Adrenergic G Protein Coupled ReceptorACS Chemical Biology, 2013
- X-ray structures of LeuT in substrate-free outward-open and apo inward-open statesNature, 2012
- Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocolEuropean Journal of Medicinal Chemistry, 2012
- Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1 ReceptorJournal of Medicinal Chemistry, 2011
- Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologueNature, 2011
- Single-molecule dynamics of gating in a neurotransmitter transporter homologueNature, 2010
- Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor AntagonistsJournal of Medicinal Chemistry, 2010
- Docking and chemoinformatic screens for new ligands and targetsCurrent Opinion in Biotechnology, 2009
- How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systemsNeuropharmacology, 2008
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004